Keratoconus patients more likely to develop sleep apnoea

Article

Keratoconus patients are more likely to develop sleep apnoea

Keratoconus patients are more likely to develop sleep apnoea, states a paper in the Journal of Cornea and External Disease.

Dr Michael Saidel, Section of Ophthalmology, University of Chicago, Illinois, USA, led a team that evaluated 92 keratoconus patients and 92 control patients. Each patient was classified as being high or low risk for sleep apnoea after answering the Berlin Questionnaire (BQ). The risk factors linked to high risk sleep apnoea was identified using logistic regression.

Out of the keratoconus patients questioned, 18 had a positive known sleep apnoea history and 49 were identified as high risk by the results of the BQ. Six of the 92 control patients had a positive known sleep apnoea history and 25 were identified as high risk.

In the control patients' age, body mass index and family history of sleep apnoea were the major risk factors for sleep apnoea. However, in keratoconus patients body mass index was the only risk factor for sleep apnoea.

The study results suggest that ophthalmologists should consider screening keratoconus patients for sleep apnoea.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.